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INTRODUCTION
Diabetes mellitus is characterized by elevated blood glucose
levels. The estimated number of people with diabetes worldwide in
2015 is 415 million, the number is expected to increase to 642
million by 2040(1) . Type 2 diabetes (T2D) makes up about 90% of
cases of diabetes(2), insulin resistance (IR) as one of the most im-
portant defect appears in various tissues (e.g., muscle, liver, and
adipose)(3).
Recent research showed that increasing ectopic triglyceride
(TG) accumulation in non-adipose tissues were associated with IR
and T2D. Adipose tissue is well known lipid storage, but has a lim-
ited maximal capacity to store lipids. Once beyond this limita-
tion, excess fatty acids would spill over into the blood, lead to
their ectopic storage in the tissues which normally contain only
small amount of fat, such as the liver, skeletal muscle, heart, and
pancreas. Ectopic fat accumulation induce metabolic processes
disruption and organ function impaired(4).
Plants are abundant in biologically active molecules that play
critical roles in pharmacology(5). Most of the available therapeutic
agents widely used for treating diabetes are associated with side
effects(6). However, natural antidiabetic products which are be-
lieved to have minimal side effects have been highlighted for the
treatment of diabetes(7, 8). Citrus sudachi is an evergreen tree that
was found mainly in Tokushima Prefecture in Japan(9, 10), and it
has been demonstrated that Citrus sudachi had the capability of
inhibiting the rising trend of blood glucose and fatty acid in human
subjects, though its mechanism has not been clarified yet (11).
AMPK (AMP-activated protein kinase) is a fuel -sensing enzyme
that plays a crucial role in response to starvation. AMPK is acti-
vated by phosphorylation of the threonine residue (Thr172) on its
catalytic α -subunit, which initiates processes such as fatty acid
oxidation that restore ATP, and inhibits ATP consumption such as
triglyceride and protein synthesis, and cell proliferation (12).
Peroxisome proliferator -activated receptors (PPARs) belong to a
subgroup in the family of nuclear hormone receptors and highly
expressed in the most of metabolic tissues. PPAR-α was the first
discovered PPARs and is known to contribute to oxidative proc-
esses including fatty acid metabolism(13). PPAR-α exists in skeletal
muscles and liver, which is closely correlated with fatty acid oxida-
tion(14). PPAR-α has been suggested as an important therapeutic
target for metabolic diseases with hyperlipidemia (15).
METHODS AND MATERIALS
Materials
We purchased AICAR, sirtinol and Gw6471 from Sigma-Aldrich,
Cosmo bio or Funakoshi Co., Ltd. (Tokyo, Japan), respectively.
Other reagents were obtained from Kanto Chemical (Tokyo,
Japan), Wako Pure Chemical (Osaka, Japan), or Tokyo Chemical
Industry (Tokyo, Japan). The following commercially available anti-
bodies were used : anti-AMPK (Sigma-Aldrich, St Louis, MO,
USA) ; anti -sirt1 (Cell Signaling Technology Japan, K.K.) ; anti-
Phospho-AMPKα (Thr172) (Cell Signaling Technology Japan, K.
K.) ; anti -β -actin, as a loading control, from Cell Signaling Tech-
nology Japan, K.K. ; anti -GAPDH, as a loading control, fromWako
Pure Chemical Industries, Ltd..
The extract process of sudachi peel
The extract process of Citrus sudachi peel was shown in Figure1.
Sudachi peel dry powder were extracted with hexane at room
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temperature for 24hr, the residue was extracted with methanol
again at the same condition, hexane extract part and methanol
extract part were separated. The methanol extract was concentrated
in 90% methanol by portioned between hexane and 90% methanol.
The fraction was chromatographed on diaion HP 20 column, eluted
with methanol and H2O solution, and then gradient and removing
the sugar dissolved in water. 5 kinds of fraction named by hydro-
phobicity from M-F1 to M-F5 were got at last.
In order to screen the function of Sudachi peel extractions, the
extractions were dissolved in dimethyl sulfoxide (DMSO), made to
different concentration.
Cell culture and treatment
Cell culture and differentiation was conducted as reported previ-
ously(16). C2C12 myoblasts, which are derived from mouse thigh
muscle cell, were obtained from American Type Culture Collec-
tion. The C2C12 myoblasts were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 4.5 g/L D-(+)-Glucose
(nacalai tesque), supplemented with 10% (v/v) fetal bovine
serum in a humidiﬁed atmosphere with 5% CO2, and grown in
DMEM supplemented with 2% horse serum for 1 week to be in-
duced differentiation into myotubes.
Triglyceride and non-essential fatty acid measurement
Following to the stimulation, lipids were extracted with 2-pro-
panol at 4 overnight, and concentrations of triglyceride (TG) and
NEFA (non-essential fatty acid) were determined by Triglyc-
eride E-test Kit and NEFA C-test Kit (Wako Pure Chemical,
Osaka, Japan) according to the manufacturer’s instruction, respec-
tively.
Oil Red O staining
Cells were fixed with 10% formalin for 1 h, rinsed with PBS for 2
times, and stained with 0.5% Oil Red O dye for 20 minutes. After
washing again with PBS, cells were visually monitored by OLYMPUS
microscopic observation.
Western blotting
After the stimulations, cells were washed with ice-cold PBS and
lysed with lysis buffer (500 mM Tris-HCl, 10 mM NaCl, 1 mM
MgCl2, 250 mM sucrose, 0.5% NP-40, 0.1 mM EGTA) as previously
reported (17-20). Protein expression and phosphorylation was de-
tected by western blot analysis. Equal amounts of proteins were
separated by 7.5% SDS-PAGE, and electrotransferred to PVDF
membranes (Millipore, USA), and then were blocked with PBS
solution with 1% Tween20 and 5% skim milk for 1 hr at room tem-
perature. Membranes were incubated with appropriately diluted
primary antibodies overnight at 4. Then incubated with the rele-
vant secondary antibodies for 2 hr at room temperature. The im-
mune complexes were visualized with the enhanced chemilumi-
nescence (ECL) detection system according to the manufacturer’s
instructions, in conjunction with ImageQuant LAS 4000 lumines-
cent image analyzer (GE Healthcare, USA). Glyceraldehyde-3-
Phosphate Dehydrogenase (GAPDH) or β -actin was served as an
internal control protein.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from cells, and was reverse-trans-
cribed using the Superscript IITM First Strand Kit (Invitrogen). We
evaluated the mRNA levels of peroxisome proliferator -activated
receptor alpha (PPARα) , sterol regulatory element-binding
protein 1 (SREBP1) , peroxisome proliferator -activated receptor
gamma coactivator 1-alpha (PGC1α) , carnitine palmitoyl trans-
ferase 1b (CPT1b) , acyl -coenzyme A oxidase (Aco) , medium
chain acyl coenzyme A dehydrogenase (MCAD) , mitochondrial
transcription factor A (mtTFA) , uncoupling protein 2 (UCP2) , and
housekeeping gene GAPDH, primer sequences are shown in
Table1. Real - time PCR was performed on an ABI PRISM 7500 PCR
System (Applied Biosystems, USA) using THUNDERBIRD SYBR
qPCRMix (TOYOBO, Japan). PCRs were carried out in a total of
20 μL as follows : one cycle at 95 for 1 min, followed by 40
cycles of 95 for 15 sec, 65 for 30 sec and 72 for 40 sec. The
gene expression from each sample was analyze in duplicates and
normalized against GAPDH. The results are expressed as relative
Figure 1 : The extract process of Citrus sudachi peel
Table 1 : Sequences of the primers used in real-time PCR
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gene expression using the ΔCt method.
Evaluation of viability
Cell viability was evaluated by MTT ((3-(4,5 -di -methylthiazol -2-
yl) -2,5 -diphenyltetrazolium bromide) assay as previously de-
scribed (12, 19, 21).
Statistical Analysis
All the data are shown as the meansstandard deviation (SD).
Student’s t - test was performed to determine the difference be-
tween two groups, and one-way ANOVA and post-hoc Tukey-
Kramer test were performed to evaluate multiple groups. P0.05
was considered statistically significant.
RESULT
Crude sudachi peel and M-F4 reduce intracellular triglyceride
level significantly in C2C12 cell.
In another paper, we demonstrated that Citrus sudachi had the
capability of inhibiting the rising trend of blood glucose and fatty
acid in human (11). We supposed that if the crude sudachi peel
could reduce intracellular Triglyceride (TG) level in C2C12 cells.
We try to find out which part of this crude extraction cause this
result. C2C12 myoblast were stimulated by 5 kinds of sudachi peel
methanol extractions (M-F1~M-F5) (100 μg/mL) for 24 hours,
only M-F4 obviously down-regulated TG level, but M-F5 had the
opposite effect (Fig 2A). The similar results were also observed
from C2C12 myotubes treated with sudachi peel methanol extrac-
tions (Fig 2B). Consistent with TG level, the neutral lipids, choles-
terol esters, and triglycerides, staining in C2C12 myotubes which
treatment with M-F4 (Fig 2C-b) was lower than the control group
(Fig 2C-a). We purposed to investigate the mechanism of this
effect.
M-F4 increases AMPK phosphorylation but did not alter Sirt1
expression.
To elucidate whether M-F4 exert a TG-lowering effect via
AMPK or Sirt1, C2C12 myotubes were treated with 100 μg/mL
M-F4 for 24hr and the protein levels were examined by western
blotting. As expected, M-F4 increased the phosphorylation of
AMPK in C2C12 myotubes obviously (Fig 3A). 5-aminoimidazole-4 -
carboxamide 1-β -D-ribofuranoside (AICAR), a specific AMPK
activator, was reported tobe used as a positive control to increase
fatty acid oxidation levels(22). Both AICAR and M-F4 increased
phosphorylation level of AMPK, but had no further combination
impact. (Fig 3D)
On the contrary, as shown in Figure 3C, the protein expression
level of Sirt1 did not significantly increased by M-F4. Sirtinol is a
non-specific Sirt1 inhibitors. Same as the treatment by M-F4, sirti-
nol (25 μM) induced a statistically insignificant trend toward re-
duced triglyceride (Fig 3E), which means that Sirt1 had no sub-
stantive role in reducing TG. Those datum were consistent with
previous western blotting results. In summary, the M-F4 caused
TG-lowering effect mediated by AMPK signaling pathway but not
involved Sirt1.
PPARα and downstream targets were involved in the AMPK
signaling pathway which caused the TG-lowering effect by M-F4.
As a master regulator of cellular energy homeostasis, AMPK has a
lot of downstream substrates. PPARα andSREBP1 are two targets
in lipid metabolism related to AMPK. Considering whether those
two targets were involved in this triglyceride reducing effect, we
used the real - time PCR to measure the mRNA level in myotubes
after 100 μg/mL M-F4 treated for 24 hr. PPARα expression was
increased by M-F4, while M-F4 did not change expression levels of
SREBP1 (Fig 4A). This triglyceride reducing effect probably medi-
ated by augment of lipid oxidation though PPARα.
In the PPARα signal pathway, a lot of downstream genes were
concerned to be involved (Fig 4B). PPAR gamma coactivator 1-
alpha (PGC-1α) is a regulator of mitochondrial biogenesis and
function, but in our experiment PGC1α were not activated by M-F4.
Carnitine palmitoyl transferase1 (CPT1b) which considered to be
the gene that controlled fatty acid mitochondrial β -oxidation were
mightily activated in 24hr by M-F4 stimulated. Considering the
genes involved in lipid oxidation, the expression of Aco, MCAD and
mtTFA were slightly increased following M-F4 treatment, but
there were no significant differences. Mitochondrial uncoupling
protein 2 (UCP2) gene expression was increased in myotubes of
M-F4 treated with statistically significant.
PPARα was the downstream target of AMPK signaling pathway
and involved in TG and NEFA reducing effect caused by M-F4.
According to some papers, the relationship between AMPK and
PPARα was a kind of complicated. In most cases, AMPK was the
upstream target of PPARα, but in some special cases PPARα was
the upstream one. In order to confirm this relationship, we use Gw
6471 as a PPARα inhibitor to treat cells. In the WB result, the
level of p-AMPK were increased by M-F4, and this increasing
trend did not change in the presence of Gw6471 (Fig 5A). In the
triglyceride measurement, the reducing effect caused by M-F4
was relieve when treated by Gw6471 (Fig 5B).
M-F4 leaded the increasing trends of PPARα, CPT1b and UCP2
were mitigated when treated with Gw6471 (Fig 5C). This result was
consistent with our expectation that CPT1b and UCP2 were the
downstream target of PPARα to reduce triglyceride level.
CPT1b is a rate limiting enzyme on the mitochondrial outer
membrane, governing long-chain fatty acid entry into mitochon-
dria. UCPs increase the proton conductance of the mitochondrial
inner membrane, eventually promote fatty acid oxidation in the
Figure 2 : Crude sudachi peel extraction and M-F4 reduced
intracellular triglyceride level in C2C12. Crude sudachi peel
extraction reduced intracellular triglyceride level in C2C12 myoblasts (A)
and myotubes (B) were stimulated by 5 kinds of extraction (100 μg/mL)
for 24 hr. The Oil Red O-positive lipid storage in C2C12 myotubes
which treatment with M-F4 (C-b) was lower than the control group
(C-a). Data are expressed as the meanSD.* : p0.05,** : p0.01
compared to vehicle control.
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mitochondrial. Therefore we conjecture the lipid reducing effect
of M-F4 not only reveal in triglyceride but also in fatty acid. In
figure 5D, we measure the non-essential fatty acid (NEFA) in the
myotubes, the result shown that M-F4 assuredly decreased the
NEFA level and decreasing tendency alleviated by Gw6471 inter-
vening.
The proposed scheme for M-F4-stimulated signaling pathway
in C2C12 myotubes was shown in Figure 7. In the lipid metabolism
process, M-F4 is primarily phosphorylated AMPK-Thr172, but
does not involve Sirt1 pathway. Then mediated by PPARα and its
downstream targets CPT1b and UCP2, ultimately leading to im-
prove lipid metabolism characterized by TG and NEFA reducing.
DISCUSSION
The aim of this research is to find the lipid lowering substance in
Citrus sudachi, and investigate its mechanism. We found that the
sudachi peel crude could reduce intracellular TG level of C2C12
cells. Moreover, M-F4, a kind of sudachi peel extractions, reduces
triglyceride of C2C12 cells. In this lipid- lowering effect, the PPARα
and its downstream targets were activated by AMPK, suggesting
that M-F4 improved the lipid metabolism characterized by TG and
NEFA reducing, via activated AMPK and mediated by PPARα
and its downstream targets CPT-1b and UCP2.
Several reports have demonstrated that citrus played important
roles in regulating glucose and lipid metabolic disorders. In the
present research, we got five kinds of methanol sudachi peel ex-
tractions. Among the kinds of extracts, M-F4 had the strongest
effect on triglyceride reducing in both myoblasts and myotubes.
Because the C2C12 myotubes were differentiated cells and have
mature cell function, we thought use the myotubes in the next ex-
periments were more close to the skeletal muscle in vivo. It is
interesting that the M-F5 was opposite to M-F4 in triglyceride
measurement, but we have not found the answer yet.
In order to find out the proper condition for the mechanism
research, we tested a series of varied concentration (1 μg/mL -
500 μg/mL) and duration (2 hr- 48 hr).
Figure 3 :M-F4 increases AMPK phosphorylation but did not alter Sirt1 expression.
C2C12 myotube were treated with 100μg/mLM-F4. The phosphorylation and expression levels of AMPK (A) and Sirt1 (C). Quantified phosphorylation
levels of AMPK (B). C2C12 myotubes were stimulated by M-F4 and treated with or without 1mM AICAR (D) and 25 μM sirtinol (E) for 24 hr.* ;
p0.05, ** ; p0.01. n.s. ; not significantly different
Figure 4 : Effects of M-F4 on mRNA levels in the expression of
AMPK-related genes.
Relative mRNA expression of metabolism-related genes in the C2C12
myotubes were treated with c or vehicle. Gene transcription of PPARα
and SREBP1 (A) were normalized for GAPDH. C2C12 myotube treated
with 100 μg/mL M-F4, the downstream genes of PPARα mRNA expres-
sion were normalized for GAPDH (B). Data are expressed as the mean
SD ; n = 3. *p0.05 and **p0.01 vs. the control.
Figure 5 : The effects of M-F4 on plasma lipids are dependent
on PPARα.
C2C12 myotubes were stimulated by M-F4 (100 μg/mL) and treated
with or without Gw6471. The proteins were examined by western blot-
ting analysis to check phosphorylation and total levels of AMPK (A).
Triglyceride (B), mRNA expression (C), and non-esterified fatty acid
(D) in the C2C12 myotube stimulated by M-F4 with or without Gw6471
(Gw). Data are expressed as the meanSD. * ; p0.05, ** ; p0.01
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In the concentration-variable experiment, while the triglyceride
reduce effect of M-F4 as 500 μg/mL was most intensely, but con-
sidering the cell viability result we got in MTT assay, we chose
concentration as 100 μg/mL in the stimulate step (Fig. 6). Since the
myotubes were differentiated by grown in DMEM supplemented
with 2% horse serum for 1 week, the differentiation also in progress
during our stimulation experiment periods. We intended the con-
trol group in every time point to avoid result changed. The re-
duction effect was start from 2 hr slightly, and became remark-
ably in 24 hr. Taking together with the MTT assay result, we
chose concentration as 100 μg/mL for 24 hr stimulation in the next
step of study.
It is known that AMPK have effect on carbohydrate and lipid
metabolism, it is already clear that the system is a major player in
the development and/or treatment of obesity, diabetes, and other
metabolic syndrome. Several natural ingredients have been shown
to exert antidiabetic effects, accompanied by AMPK activation.
Thus, we first hypothesized that sudachi peel extraction reduce
triglyceride effect is likely to be related to AMPK. In addition, Sirt1
always has a complicated relationship with AMPK in many meta-
bolic regulate fields. But in our Western Blotting assay, only AMPK
related proteins were activated obviously. In the following experi-
ment, sirtinol and AICAR were used to intervene the expression of
Sirt1 and AMPK, the results were consistent with previous ones. It
means that AMPK should be involved in the TG reducing effect
caused by M-F4, and this effect may depended on some other
AMPK-related target but not Sirt1.
PPARs act as fatty acid sensors to control many metabolic pro-
grams that are essential for systematic energy homeostasis. Fig. 4A
and 5B-D demonstrates that M-F4 exerts triglyceride reducing
effect by activating PPARα. There also reported that naringenin
treatment lowers triglyceride and cholesterol in plasma and liver
with increasing PPARα expression in rat liver (23). PPARα null
mice have decreased expression of cardiac fatty acid oxidation
genes and decreased rates of fatty acid oxidation, but maintain
normal cardiac function. PPARα/γmay exert the synergic inhibi-
tory effects on fatty acid synthesis by controlling the expressions of
the transcription factor SREBP-1c, though this does not corre-
spond with our results.
The target genes regulated by PPARα and involved in lipid me-
tabolism and obesity include PGC1α, CPT1b, MCAD, UCP2, ACO
and mtTFA. PGC1α has been implicated in increasing the oxida-
tion of fatty acids via increasing mitochondrial capacity and func-
tion, making this co- factor a key candidate for the treatment of
lipotoxicity recently. Unexpectedly, the expression level of PGC1α
were declined by stimulation, which is probably because PGC1α
activity is also altered via AMPK and Sirt1 pathways. Some reports
showed that synergistic activation of CPT1b gene is promoted by
heterodimer nuclear receptors PPARα -RXRα. Increase in CPT1
expression in muscle can recover insulin sensitivity and reduce
lipid accumulation. Our current results exactly suggest that TG
reducing effect is mediated by augment of lipid oxidation through
PPARα -CPT1b pathway. UCP2 is expressed and functionally
active in both central and peripheral tissues involved in glucose and
lipid metabolism. It was reported that obesity could be treated by
promoting the activity of native UCP. Tsutsumi also reported that
UCP2 gene expression was significantly increased in skeletal
muscle of mice which improved glucose and lipid metabolism (9).
Molecular mechanisms how M-F4 exerts the lipid- lowering ef-
fects we propose is summarized in Fig. 7.
We considered if M-F4 improves lipid metabolism by reducing
TG only, or it could effect on other lipid substance. Consistent with
our expectation, M-F4 improved the lipid metabolism character-
ized by both TG and NEFA (Fig. 5D).
CONCLUSION
In summary, our study is the first to demonstrate that sudachi
peel methanol extract reduces triglyceride and fatty acid level in
skeletal muscle cell. Additionally, our findings suggest that M-F4
improves lipid metabolism through AMPK, PPARα and their
downstream targets, CPT-1b and UCP2. Furthermore, these ob-
servations indicate that this extract may be useful for preventing
obesity and diabetes related diseases.
Figure 6 : The effects of M-F4 on cell viability.
Viability of C2C12 cells were determined by MTT assay 24 (circle), 48
(triangle), or 72 (square) hr after exposure to indicated concentra-
tion of M-F4, respectively. ** ; p0.01 vs vehicle control.
Figure 7 : Proposed scheme for M-F4-stimulated signaling
pathway in C2C12 myotubes.
In the lipid metabolism process, M-F4 is primarily dependent on AMPK
activation, which does not involve Sirt1 pathway. Then mediated by
PPARα, CPT1b and UCP2, ultimately lead to amplify the β -oxidation.
Simultaneously induce to fatty acid and triglyceride level reduce in the
C2C12 myotubes.
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